The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329
Crystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Cell · doi:10.1016/0092-8674(86)90779-8 · Cited by 1,006
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.-M., Maroteaux, P., Merrer, M. L., & Munnich, A. (1994) · Nature · doi:10.1038/371252a0 · Cited by 928
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0496-390 · Cited by 873
Self-citationActivation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., & Leder, P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.240 · Cited by 632
Self-citation
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Self-citationThe FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
“Kinase-domain FGFR3 mutations increase catalytic activity independently of receptor dimerizatio”
Reaching a Genetic and Molecular Understanding of Skeletal Development
Karsenty, G., & Wagner, E. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00157-0 · Cited by 1,601
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., & Schlessinger, J. (1997) · Science · doi:10.1126/science.276.5314.955 · Cited by 1,097
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Self-citationVascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Genetic Control of Bone Formation
Karsenty, G., Kronenberg, H. M., & Settembre, C. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113308 · Cited by 667
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Kinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Horton, W. A., Hall, J. G., & Hecht, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61090-3 · Cited by 582
Perlecan is essential for cartilage and cephalic development
Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R., & Yamada, Y. (1999) · Nature Genetics · doi:10.1038/15537 · Cited by 542
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Gavine, P. R., Mooney, L., Kilgour, E., Thomas, A. P., Al-Kadhimi, K., Beck, S., Rooney, C., Coleman, T., Baker, D., Mellor, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3034 · Cited by 501
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors
Billerey, C., Chopin, D., Aubriot-Lorton, M.-H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.-P., Lefrere-Belda, M.-A., Lahaye, J.-B., Abbou, C. C., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64665-2 · Cited by 498
Achondroplasia: a comprehensive clinical review
Pauli, R. M. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0972-6 · Cited by 491
Minina, E., Kreschel, C., Naski, M. C., Ornitz, D. M., & Vortkamp, A. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00261-7 · Cited by 475
Self-citationNaski, M. C., Colvin, J. S., Coffin, J. D., & Ornitz, D. M. (1998) · Development · doi:10.1242/dev.125.24.4977 · Cited by 420
Self-citationFibroblast growth factor signaling in skeletal development and disease
Ornitz, D. M., & Marie, P. J. (2015) · Genes & Development · doi:10.1101/gad.266551.115 · Cited by 418
Self-citationThe Heparan Sulfate–Fibroblast Growth Factor Family: Diversity of Structure and Function
McKeehan, W. L., Wang, F., & Kan, M. (1997) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)61031-4 · Cited by 392
Transcriptional Control of Skeletogenesis
Karsenty, G. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164437 · Cited by 391
Murakami, S., Kan, M., McKeehan, W. L., & de Crombrugghe, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1113 · Cited by 377
Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism
Mohammadi, M., Schlessinger, J., & Hubbard, S. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80131-2 · Cited by 370
FGF signaling in the developing endochondral skeleton
Ornitz, D. M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.02.003 · Cited by 356
Self-citationVajo, Z., Francomano, C. A., & Wilkin, D. J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0387 · Cited by 350
Hernández, S., López-Knowles, E., Lloreta, J., Kogevinas, M., Amorós, A., Tardón, A., Carrato, A., Serra, C., Malats, N., & Real, F. X. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1771 · Cited by 334
Mutations that Cause Osteoglophonic Dysplasia Define Novel Roles for FGFR1 in Bone Elongation
White, K. E., Cabral, J. M., Davis, S. I., Fishburn, T., Evans, W. E., Ichikawa, S., Fields, J., Yu, X., Shaw, N. J., McLellan, N. J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427956 · Cited by 323
Self-citationThe role of immunoglobulin translocations in the pathogenesis of B-cell malignancies
Willis, T. G., & Dyer, M. J. S. (2000) · Blood · doi:10.1182/blood.v96.3.808 · Cited by 323
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome
Xiao, S., Nalabolu, S. R., Aster, J. C., Ma, J., Abruzzo, L., Jaffe, E. S., Stone, R., Weissman, S. M., Hudson, T. J., & Fletcher, J. A. (1998) · Nature Genetics · doi:10.1038/ng0198-84 · Cited by 323
Autoregulatory Mechanisms in Protein-tyrosine Kinases
Hubbard, S. R., Mohammadi, M., & Schlessinger, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.11987 · Cited by 318
FGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A., & Muenke, M. (1996) · Nature Genetics · doi:10.1038/ng1096-174 · Cited by 316
Su, W.-C. S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., & Fu, X.-Y. (1997) · Nature · doi:10.1038/386288a0 · Cited by 304
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Fukada, T., Civic, N., Furuichi, T., Shimoda, S., Mishima, K., Higashiyama, H., Idaira, Y., Asada, Y., Kitamura, H., Yamasaki, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003642 · Cited by 287
“The gain-of-function mutant of Fgfr3 causes achondroplasia [51], Sox9 controls chondrocyte differentiation via Sox5 and Sox6 expression [52], and Ihh is a master gene of bone development under BMP control Role of ZIP13 in Development”
BackgroundA Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
Hart, K. C., Robertson, S. C., Kanemitsu, M. Y., Meyer, A. N., Tynan, J. A., & Donoghue, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203650 · Cited by 276
Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation
Mol, C. D., Lim, K. B., Sridhar, V., Zou, H., Chien, E. Y. T., Sang, B.-C., Nowakowski, J., Kassel, D. B., Cronin, C. N., & McRee, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300186200 · Cited by 274
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
The genetic basis for skeletal diseases
Zelzer, E., & Olsen, B. R. (2003) · Nature · doi:10.1038/nature01659 · Cited by 272
Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
Belov, A. A., & Mohammadi, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015958 · Cited by 271
Depew, M. J., Tucker, A. S., & Sharpe, P. T. (2002) · Mouse Development · doi:10.1016/b978-012597951-1/50023-8 · Cited by 259
Achondroplasia: Development, pathogenesis, and therapy
Ornitz, D. M., & Legeai‐Mallet, L. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24479 · Cited by 259
Self-citationLoss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
Yu, K., Herr, A. B., Waksman, G., & Ornitz, D. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14536 · Cited by 258
Self-citationAntibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Qing, J., Du, X., Chen, Y., Chan, P., Li, H., Wu, P., Marsters, S., Stawicki, S., Tien, J., Totpal, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38017 · Cited by 255
Self-citationFoldynova-Trantirkova, S., Wilcox, W. R., & Krejci, P. (2012) · Human Mutation · doi:10.1002/humu.21636 · Cited by 216
The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis
Hevner, R. F. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1059-8 · Cited by 106
A germline mutation in KIT in familial diffuse cutaneous mastocytosis
Tang, X., Boxer, M., Drummond, A., Ogston, P., Hodgins, M., & Burden, A. D. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015156 · Cited by 81
Maher, G. J., McGowan, S. J., Giannoulatou, E., Verrill, C., Goriely, A., & Wilkie, A. O. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521325113 · Cited by 59
Metadata
- Authors
- Naski, M. C., Wang, Q., Xu, J., & Ornitz, D. M.
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 233-237
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1981856729
- Cited by
- 498
- References
- 28
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.